Mufaso
6 minutes ago
I don’t think the change in control clause the route Teoxane is going to terminate the agreement. Todays 8-K says:
On August 16, 2024, Revance Therapeutics, Inc. (the “Company” or “Revance”) received a notice to remedy alleged material breaches, including breaches of the maximum levels of